ClinicalTrials.gg
CompletedNCT07621588KOTS-LCUpdated Sep 29, 2026

Diaphragmatic Breathing Exercises With KOTS Currents in Patients With Long COVID

An interventional study of Diaphragmatic Electrostimulation Using KOTS Currents and Diaphragmatic Breathing Exercises in Long COVID Syndrome and Post-Acute COVID-19 Syndrome, sponsored by Universidad Pontificia de Salamanca. Completed at 1 site in Spain. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-09-29.

Sponsored by Universidad Pontificia de Salamanca · Not applicable, Interventional, and Treatment

How we know

Updated Sep 29, 2026Now CompletedStudy completion moved+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
9
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 52 studies in Post-Acute COVID-19 Syndrome with a site in Spain — 13 open to participants now, 16 under way, 1 of them phase 3. Post-Acute COVID-19 Syndrome · Spain.

Enrollment
39th of 39
9 · median 60
Started
2026
with 4 others
No phase
31 of 52
7 open now
Registered
49th of 52
by date

Among the 52 studies in Post-Acute COVID-19 Syndrome with a site in Spain, this one is the 39th largest by enrollment of the 39 interventional ones that give a count, is one of 5 that started in 2026, is one of 31 with no phase, and was the 49th registered.

Post-Acute COVID-19 Syndrome

606 studies on the registry are indexed under Post-Acute COVID-19 Syndrome; 201 are open to participants now.

Browse Post-Acute COVID-19 Syndrome studies →

Open to participants now

13 of the 52 studies in Post-Acute COVID-19 Syndrome with a site in Spain are open now. Recruiting first, the newest first:

8 more — sign in →

All 13 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 144 Post-Acute COVID-19 Syndrome studies recruiting now, 69 (48%) set no upper age limit and 53 (37%) stop at 75 or younger; 15 take children under 18; 39 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 52 studies in Post-Acute COVID-19 Syndrome with a site in Spain, or all of them as a file.
02

Study summary

This study will evaluate the effects of diaphragmatic breathing exercises combined with diaphragmatic electrostimulation using KOTS currents in patients with Long COVID. Participants will be randomly assigned to one of two groups. The control group will perform diaphragmatic breathing exercises, while the intervention group will perform diaphragmatic breathing exercises combined with diaphragmatic electrostimulation using KOTS currents. The intervention will last three weeks, with two sessions per week. The study will assess respiratory function, quality of life, physical function, dyspnea, fatigue, and basal oxygen saturation.

Read the detailed description

Long COVID is a multifactorial condition that may be associated with persistent respiratory symptoms, reduced physical capacity, fatigue, dyspnea, and impaired quality of life. Respiratory rehabilitation strategies may contribute to improving breathing patterns and functional recovery in this population. Diaphragmatic breathing exercises are commonly used to promote respiratory control and diaphragmatic activation. In addition, KOTS currents, also known as Russian currents, are medium-frequency alternating currents used in physiotherapy to elicit muscle contraction and may be applied as a complementary strategy to stimulate the diaphragm.

This pilot randomized controlled trial will compare diaphragmatic breathing exercises alone with diaphragmatic breathing exercises combined with diaphragmatic electrostimulation using KOTS currents in patients diagnosed with Long COVID. Participants will be randomly allocated to either the control group or the intervention group. Both groups will receive a three-week intervention consisting of two sessions per week. The control group will perform diaphragmatic breathing exercises, whereas the intervention group will perform the same breathing exercises combined with diaphragmatic electrostimulation.

Assessments will be conducted before and after the intervention period. The study is intended to explore whether adding diaphragmatic electrostimulation to a respiratory exercise program may provide additional benefits compared with diaphragmatic breathing exercises alone in this population.

03

Conditions studied

  • Long COVID Syndrome
  • Post-Acute COVID-19 Syndrome

Keywords

  • Diaphragmatic Breathing
  • KOTS Currents
  • Russian Currents
  • Diaphragmatic Electrostimulation
  • Quality of Life
  • Respiratory Rehabilitation
  • Spirometry
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Men and women aged 18 to 65 years.
  • Medical diagnosis of Long COVID.
  • At least 2 months since SARS-CoV-2 infection.
  • Ability and willingness to provide .
  • Ability to participate in the assigned intervention and assessment procedures.

Exclusion criteria

Exclusion Criteria:

  • Presence of a pacemaker.
  • History of epilepsy.
  • Pregnancy.
  • History of acute cardiac arrest.
  • Severe respiratory distress.
  • Use of a wheelchair.
  • Blurred vision.
  • Cyanosis.
  • Refusal to perform part or all of the treatment.
  • Incomplete or incorrectly completed questionnaires.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
9 participants (actual)

Study arms

  • Experimental
    Diaphragmatic Breathing Exercises Plus KOTS Currents

    Participants assigned to this arm will perform diaphragmatic breathing exercises combined with diaphragmatic electrostimulation using KOTS currents. The intervention will be delivered twice per week for three weeks. KOTS currents will be applied as medium-frequency alternating current stimulation, with stimulation intensity adjusted according to participant tolerance.

    Device: Diaphragmatic Electrostimulation Using KOTS Currents · Behavioral: Diaphragmatic Breathing Exercises

  • Active comparator
    Diaphragmatic Breathing Exercises

    Participants assigned to this arm will perform diaphragmatic breathing exercises twice per week for three weeks. Exercises will be performed in a supine position, with slow nasal inspiration and abdominal expansion followed by slow exhalation through pursed lips.

    Behavioral: Diaphragmatic Breathing Exercises

Interventions

  • DeviceDiaphragmatic Electrostimulation Using KOTS Currents

    Diaphragmatic electrostimulation will be applied using KOTS currents, a medium-frequency alternating current stimulation. Electrodes will be placed over the seventh and eighth rib region along the mammillary line. Stimulation will be delivered in trains of 4 seconds of stimulation followed by 8 seconds of rest, with a carrier frequency of 2,500 Hz. The standard treatment duration will be 15 minutes: 10 minutes at 30 Hz followed by 5 minutes at 70 Hz. Stimulation intensity will be adjusted according to participant tolerance. The intervention will be delivered twice per week for three weeks, together with diaphragmatic breathing exercises.

    Also known as: KOTS Currents, Russian Currents

  • BehavioralDiaphragmatic Breathing Exercises

    Participants will perform diaphragmatic breathing exercises in a supine position with the knees flexed. One hand will be placed on the chest and the other hand below the sternum. Participants will be instructed to inhale through the nose while expanding the abdomen with minimal thoracic movement, and to exhale slowly through pursed lips. The breathing pattern will include a 4-second inspiration and a 6-second expiration. Exercises will be performed twice per week for three weeks.

    Also known as: Diaphragmatic Breathing

06

What researchers measure

Primary outcomes

  1. Forced Vital Capacity

    Forced vital capacity will be assessed using spirometry. The outcome will evaluate the change in forced vital capacity from baseline to after the three-week intervention.

    Time frame: Baseline and 3 weeks

Secondary outcomes

  1. Forced Expiratory Volume in One Second

    Forced expiratory volume in one second will be assessed using spirometry. The outcome will evaluate the change in FEV1 from baseline to after the three-week intervention.

    Time frame: Baseline and 3 weeks

  2. Peak Expiratory Flow

    Peak expiratory flow will be assessed using spirometry. The outcome will evaluate the change in PEF from baseline to after the three-week intervention.

    Time frame: Baseline and 3 weeks

  3. FEV1/FVC Ratio

    The FEV1/FVC ratio will be calculated from spirometry measurements. The outcome will evaluate the change in the FEV1/FVC ratio from baseline to after the three-week intervention.

    Time frame: Baseline and 3 weeks

  4. Basal Oxygen Saturation

    Basal oxygen saturation will be measured using a finger pulse oximeter. The outcome will evaluate the change in basal oxygen saturation from baseline to after the three-week intervention

    Time frame: Baseline and 3 weeks

  5. Physical Function

    Physical function will be assessed using the 30-second Sit-to-Stand test. The outcome will evaluate the change in the number of completed sit-to-stand repetitions from baseline to after the three-week intervention

    Time frame: Baseline and 3 weeks

  6. Dyspnea

    Dyspnea will be assessed using the modified Medical Research Council scale. The outcome will evaluate the change in perceived dyspnea from baseline to after the three-week intervention. Lower scores indicate lower dyspnea.

    Time frame: Baseline and 3 weeks

  7. Quality of Life with SF-36 questionnaire

    Quality of life will be assessed using the SF-36 questionnaire. The outcome will evaluate the change in quality-of-life dimensions from baseline to after the three-week intervention. Higher scores indicate better quality of life.

    Time frame: Baseline and 3 weeks

  8. Fatigue

    Fatigue will be assessed using the DePaul Symptom Questionnaire. Higher scores indicate greater fatigue.

    Time frame: Baseline and 3 weeks

07

Study locations

1 site
  • Clínica Universitaria Salus Infirmorum, Universidad Pontificia de Salamanca
    Madrid, Madrid 28015, Spain
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared because the study involves health-related data from a small sample of participants. Data will be pseudonymized and handled in accordance with applicable data protection regulations and the informed consent approved for the study.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jun 2026 to primary completion in Jul 2026, 1 month.

Of 232 non-industry interventional studies with no phase under Post-Acute COVID-19 Syndrome, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 28. This study's 1 month is below that.

Counting every sponsor, half of 243 studies reached it within 16 months; a quarter within 7 and three quarters within 27.

Completion moved once since we started tracking on Sep 25, 2026: Jul 2026 → Aug 2026, on Sep 29, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
May 27, 2026
First posted
Jun 2, 2026
StartActual
Jun 14, 2026
Primary completionActual
Jul 31, 2026
CompletionActual
Aug 7, 2026was Jul 2026
Last update
Sep 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Completed
changed Sep 29, 2026
Study completion
Jul 2026→Aug 7, 2026 (actual)
Sep 29, 2026
Enrollment
10 (estimated)→9 (actual)
Sep 29, 2026
Show all 1 update
  1. Sep 29, 2026
    Not yet recruiting→Completed
    Study completion Jul 2026→Aug 7, 2026 (now actual)
    Enrollment 10 (estimated)→9 (actual)
    + 2 other changes: verification date and contact details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07621588
Lead sponsor
Universidad Pontificia de Salamanca
Responsible party
Sara Perpiñá (Principal investigator and Professor of Physiotherapy, Universidad Pontificia de Salamanca) — Principal investigator
First posted
Jun 2, 2026
Start date
Jun 14, 2026
Primary completion
Jul 31, 2026
Completion
Aug 7, 2026
Last update
Sep 29, 2026

Study contacts

Sara Perpiña-Martínez
principal investigator · Pontifical University of Salamanca

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion